Jiukuan Hao Selected Research

Isoflurophate (DFP)

1/2017

4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiukuan Hao Research Topics

Disease

8	Inflammation (Inflammations) 07/2022 - 11/2014
6	Ischemic Stroke 07/2022 - 11/2014
5	Infarction (Infarctions) 01/2022 - 04/2015
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2022 - 02/2008
4	Brain Ischemia (Cerebral Ischemia) 01/2022 - 02/2008
4	Stroke (Strokes) 01/2022 - 02/2008
4	Neuroinflammatory Diseases 01/2022 - 11/2014
2	Neuroblastoma 01/2022 - 04/2015
2	Brain Injuries (Brain Injury) 01/2022 - 01/2022
2	Cognitive Dysfunction 01/2022 - 01/2022
2	Edema (Dropsy) 01/2022 - 01/2022
2	Ischemia 08/2020 - 01/2013
1	Carcinoma (Carcinomatosis) 07/2022
1	Encephalitis (Encephalitis, Rasmussen) 07/2022
1	Wounds and Injuries (Trauma) 07/2022
1	Brain Infarction 07/2022
1	Neoplasms (Cancer) 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Sepsis (Septicemia) 11/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2013

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2022 - 11/2015
4	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2017
2	Prostaglandin-E SynthasesIBA 01/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 01/2022
2	EnzymesIBA 01/2022 - 01/2022
2	Prostaglandins EIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2013
2	Oxidopamine (6 Hydroxydopamine)IBA 01/2017 - 01/2017
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2015 - 02/2008
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 07/2022
1	LigandsIBA 07/2022
1	Polysaccharides (Glycans)IBA 07/2022
1	Tyrosine (L-Tyrosine)FDA Link 07/2022
1	InflammasomesIBA 01/2022
1	NLR ProteinsIBA 01/2022
1	NucleotidesIBA 01/2022
1	Angiotensin IIIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	TG6-10-1IBA 08/2020
1	cembra-2,7,11-triene-4,6-diolIBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	Isoflurophate (DFP)FDA Link 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	OligodeoxyribonucleotidesIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	GW 4869IBA 11/2015
1	Glucose (Dextrose)FDA LinkGeneric 04/2015
1	Oxygen (Dioxygen)IBA 04/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2015
1	WortmanninIBA 04/2015
1	Small Interfering RNA (siRNA)IBA 11/2014
1	RNA (Ribonucleic Acid)IBA 11/2014
1	Flurbiprofen (Froben)FDA LinkGeneric 01/2013
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2013
1	MicellesIBA 01/2013
1	SolventsIBA 01/2013
1	AminesIBA 02/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2008
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 02/2008

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2022